FierceBiotech

The Swiss drugmaker has plucked an experienced scientist from Down [...]

Novartis has jettisoned an anti-cancer protein from its pipeline after [...]

Politico has reported that the White House isn’t happy with [...]

Johnson & Johnson has paused further enrollment in a phase [...]

Sanofi has backed the $75 million series B of a [...]

In a deal with Theriva Biologics potentially worth as much [...]

Only a couple of months ago, Sensei Biotherapeutics was laying [...]

Unnatural Products is proving to be a natural at securing [...]

Boehringer Ingelheim is discarding an inhaled gene therapy designed to [...]

Japan-based cell therapy company Innovacell is planning to end a [...]